The selective 5-HT1A receptor biased agonist, NLX-101, corrects anomalous behavioral phenotype in a mouse model of fragile X syndrome.

Electroencephalography signals in a female Fragile X Syndrome mouse model.

Contribution of astrocytic calcium signaling to auditory hypersensitivity in a mouse model of fragile X syndrome.

Psychiatric and Cognitive Features in Italian Women With the FMR1 Premutation: A Comprehensive Assessment Using SCID-5 and Standardized Cognitive Measures.

An Autopsy Case With Fragile X-Associated Tremor/Ataxia Syndrome Presenting Intranuclear Inclusion Bodies Mainly in the Limbic System.

Local Translation in Glial Cells of the Brain.

Factors associated with social participation among children with fragile X syndrome.

The Management of Evolving Neuropsychiatric Symptoms in a Female with Fragile X Syndrome: A Case Report.

Stimulation of the medial septum diagonal band of broca rescues learning and memory deficits in Fmr1 KO mice.

Unraveling the mechanisms of slack channel mutations in epileptic disorders.

Elevated gamma spectral event peak power during auditory chirp is associated with neuropsychiatric features in Fragile X syndrome.

Extracellular spike waveform analysis reveals cell type-specific changes in the superior colliculus of fragile X mice.

Foundations of an Ovine Model of Fragile X Syndrome.

Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation Strategies.

Allele-specific alternative polyadenylation links noncoding genetic variation to Alzheimer's disease risk.

Directed Teaching of Clinical Reasoning in the Fourth Year of Medical School: A Structured Summary of Genetic Observations.

Communicative Development Inventories (CDIs) in etiologically diverse developmental conditions: A systematic review.

Up-regulation of Minibrain/DYRK1A contributes to macrocephaly and brain overgrowth in a Drosophila model of fragile X syndrome.

Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.

Bioisostere-Driven Discovery of SePP: A Selenium-Containing Polypharmacological Agent Relevant to Fragile X Syndrome.

A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-/y mice.

Alpha oscillations are dysrhythmic in Fragile X syndrome.

Behavioral Phenotype Associations With Resting State EEG Signal Complexity and Power Spectral Density in Fragile X Syndrome.

GABAB Receptor signaling in CA1 Pyramidal Cells is not Regulated by Aging in the APP/PS1 Mouse Model of Amyloid Pathology.

Hippocampal glial alterations are associated with Lamin B1 dysregulation and abnormal nuclear morphology in a rat model of fragile X syndrome.

Genetic diagnosis of three intellectually disabled individuals in a pedigree and insights into fragile X syndrome diagnosis.

Targeting autophagy for postsynaptic organization and cognitive rescue in Fragile X syndrome.

The apolipoprotein gene: a modulating role on brain volume and cognitive function in carriers of the fragile X premutation.

FMR1 RNA interaction with DNMT1 blocks DNA methylation at the FMR1 locus.

Elevated somatostatin interneuron long-term potentiation minimally regulates temporoammonic plasticity in a mouse model of Fragile X Syndrome.

Olfactory Deficits in Fragile X Syndrome.

Metabolic reprogramming during human neuron differentiation indicates glutaminase as a key determinant in Fragile X syndrome.

Cognitive dysfunction in women with the FMR1 premutation during midlife: The LASSI-L reveals curvilinear CGG-dependent risk buffered by college education.

From Concerns to Care: Understanding Parental Priorities and Access to Early Intervention for Infants With Fragile X Syndrome.

Autism Observation Scale for Infants: Systematic Review and Meta-Analysis in Samples at Increased Likelihood of Autism Spectrum Disorders.

Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and altered bile pathway gene expression.

Screening of CGG Trinucleotide Repeats Within FMR1 Gene in Bangladeshi Children With Autism Spectrum Disorder: Exploring a Possible Link With Fragile X Syndrome.

Integrative transcriptome-wide association analyses reveal PRKCG-linked GABAergic dysfunction in Fragile X-associated tremor/ataxia syndrome.

Explaining the Comprehension-Production Vocabulary Gap Through Neural Networks and Cross-Syndrome Evidence: Insights From Williams Syndrome.

Elevated serotonin receptor 2A signaling restores learning and memory in a Fragile X syndrome model.

Alterations in electroencephalography signals in female fragile X syndrome mouse model on a C57BL/6J background.

Therapeutic GSK-3β targeting stabilizes multifunctional β-catenin to rescue neuronal and behavioral deficits in fragile X messenger ribonucleoprotein 1 knockout mice.

FMRP restoration in parvalbumin interneurons: A circuit-specific improvement of visual learning in fragile X syndrome.

Dysfunctional neural dynamics associated with sensory phenotypes in Fragile X syndrome: insights from mouse models.

Alterations in auditory midbrain processing is observed in both female and male mouse model of Fragile X Syndrome.

Expanding the spectrum of AFF2 undifferentiated sarcoma associated to endometriosis: a novel ZDHHC9::AFF2 fusion sarcoma with high-grade features and poor prognosis.

Astrocytic GABA controls fidelity of temporal cortical processing in Fragile X Syndrome.

Carrier screening for multiple complex monogenic diseases using long-read sequencing: a population-based study of premarital couples in Shanghai.

The impact of individual factors on linguistic alignment of autistic boys and their mothers.

Early postsynaptic potentiation in hippocampal somatostatin interneurons is mTORC1-dependent and disrupted in Fmr1-/y mice.

Altered Auditory Maturation in Fragile X Syndrome and Its Involvement in Audiogenic Seizure Susceptibility.

An Out-of-Place Etiology: Recognizing FMR1 Premutation in the Memory Clinic.

Detection of FMR1 CGG Repeat Expansions Using Buccal Swab and Blood Samples of Children With Intellectual Disability in A Resource-Limited Country.

Uncovering novel endocannabinoidome-gut microbiome-brain axis-based therapeutic targets in a Fragile X Syndrome mouse model.

Generation and characterization of a human-derived iPSC line (HZSMHCi003-A) from a male child with fragile X syndrome.

IGF2BPs directly regulate the noncanonical translation of toxic proteins from mutant FMR1 mRNA containing expanded CGG repeats.

Introducing the kollaR package: A user-friendly open-access solution for eye-tracking analysis and visualization.

Microbiome modulation and behavioural improvements in children with fragile X syndrome following probiotic intake: A pilot study.

iTBS Improves Behavioral Abnormalities and Synaptic Defects in Fmr1 KO Rats by Regulating the Autophagy Pathway.

Overlapping Pathways: Autism Spectrum Disorder in Fragile X Carrier States and the Need for Greater Awareness.

Attention skills, learning and academic abilities in children and adolescents with genetic disorders: a systematic review.

Regulatory Functions of TDP-43 and FMRP in Non-Neuronal Diseases: Are Co-Targeted mRNAs the Keys?

Cell-intrinsic mechanisms underlying spontaneous activity in the mouse visual cortical slice: implications for fragile X pathophysiology.

Delayed onset of striatal projection neuron hyperexcitability in Fmr1-/y mice.

Evidence of spontaneous mentalizing in children with Cornelia de Lange and fragile X syndromes, but not autistic children.

Reduced Sensorimotor, Working Memory, and Episodic Memory Abilities in Aging Female FMR1 Premutation Carriers with and Without Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).

Swallowing and choking difficulties as potential markers of FXTAS progression in FMR1 premutation carriers.

Disrupted theta synchronization and synaptic connectivity in the visual cortex of Fmr1 KO mice.

Effects of Metformin on children with Fragile X Syndrome: a randomized, double-blind, placebo-controlled trial.

Atypical Inter-Brain Synchrony and Social Communication Deficits in Girls with Fragile X Syndrome: Evidence from Functional Near-infrared Spectroscopy Hyperscanning.

Aberrant Neural Entrainment to Word-Level Speech Patterns in Fragile X Syndrome: Evidence for a Statistical Learning Deficit.

Long-read sequencing reveals extensive FMR1 somatic mosaicism in Fragile-X associated tremor/ataxia syndrome in human brain.

A rapid and dynamic role for FMRP in the plasticity of adult neurons.

Enhanced CB1 receptor function in GABAergic neurons mediates hyperexcitability and impaired sensory-driven synchrony of cortical circuits in Fragile X Syndrome model mice.

Early Pragmatic Communication in Autism and Fragile X Syndrome.

Behavioral and molecular insights into anxiety in ube3a and fmr1 zebrafish models of autism spectrum disorders.

Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension study.

RNA-based therapies for neurodevelopmental disorders: innovative tools for molecular correction.

Harnessing the microbiota-gut-brain axis to prevent and treat pediatric neurodevelopmental disorders: translational insights and strategies.

Age-varying distinct neuroanatomy in young children with autism spectrum disorder and fragile X syndrome.

Exploring the impact of metformin on the central nervous system and neurotransmission: A systematic review.

Improving women's healthcare providers' knowledge about fragile X-associated primary ovarian insufficiency through a novel educational tool.

Gene Therapy for Fragile X Syndrome, Challenges, and Promises.

From Mutations to Microbes: Investigating the Impact of the Gut Microbiome on Repeat Expansion Disorders.

KCNT1 (Slack/Slo2.2) and KCNT2 (Slick/Slo2.1) Dysregulation in Intellectual Disability and Behavioral Phenotypes: A Systematic Review.

The imperative for multigenerational genetic screening: A case report of fragile X-associated tremor/ataxia syndrome (FXTAS).

Aberrant hippocampal gamma oscillations in a mouse model of fragile X syndrome: insights from in vitro slice models.

Exome sequencing in severe non-syndromic specific learning and language disorders in a French cohort.

Clinical Utility and Performance of Methylation-Specific Triplet-Primed PCR for Fragile X Syndrome Diagnosis.

The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum Disorder.

Personalized Follow Up and Genetic Diagnosis Update of FMR1-Related Conditions: A Change in Diagnosis, Prognosis and Expectations.

Extracellular Vesicles-Dependent Secretion Regulates Intracellular CYFIP2 Protein Homeostasis in Cortical Neurons.

FMR1 Premutation Carrier Mothers' Daily Negative Affect and Cortisol: Probing the Impacts of Stress Exposure, Coping Style, and CGG Repeats.

Relationship Between Intellectual Disability and Behavioral Comorbidity in Children With Fragile X Syndrome.

Brief Report: Differences Between Stanford-Binet Abbreviated and Full-Scale Estimates of IQ in Fragile X Syndrome Vary Across Development.

A missense variant in the KH0-domain of FMRP downregulates the protein in a patient with the clinical hallmarks of fragile X syndrome.

Comparing loss of individual fragile X proteins suggests strong links to cellular senescence and aging.

Behavioral benefits of GSK-3β inhibition and state-dependent microtubule signatures in the Fmr1-KO mouse.

Combined Treatment with Minocycline and an mGluR5 Antagonist Alters Resting EEG Spectral Power, but Not Sound-Evoked Responses, in a Mouse Model of Fragile X Syndrome.

FRAXE-associated intellectual disability: clinical and molecular insights into an underdiagnosed condition.

Prevalence of Fragile X syndrome in Georgian patients with autism spectrum disorder and/or intellectual disability: cross-sectional study and review of current approaches.

CRISPR activation of the ribosome-associated quality control factor ASCC3 ameliorates fragile X syndrome phenotypes in mice.

Associations Between Altered Auditory EEG Markers and Clinical Impairments in Fragile X Syndrome.

Beyond the Fragile X protein: neighborhood characteristics explain individual differences in IQ and adaptive behaviors of Fragile X syndrome.

Evaluating DNA methylation episignatures as a first-tier diagnostic test in individuals with suspected genetic disorders.

Altering rRNA 2'O-methylation pattern during neuronal differentiation is regulated by FMRP.

Serum Metabolic and Gut Microbiome Differences in Age-Associated Fragile X Syndrome (FXS) Pediatric Patients May Benefit Clinical Therapy Development.

Sleep in a mouse model of fragile X syndrome is resistant to metabolic manipulations.

Multidimensional Characterisation of Eating Behaviour in Genetic Obesity: A Systematic Review.

Psychiatric Condition Management in Primary Care for Adults with Intellectual and Developmental Disabilities.

Divergent aperiodic slope and alpha dynamics expose cortical excitability gradients in fragile X syndrome.

Repurposing Nitazoxanide to target the expanded r(CGG)n repeat RNA for therapeutic intervention in fragile-X tremor/ataxia syndrome.

FX ENTRAIN: scientific context, study design, and biomarker driven brain-computer interfaces in neurodevelopmental conditions.

Impact of brief telehealth interventions on parental stress and challenging behaviors of children with fragile X syndrome.

Clinical, Genetic and Molecular Divergences Between Full Mutation and Premutation in Fragile X Syndrome: A Systematic Review.

Delayed structural maturation of inner hair cell ribbon synapses in a mouse model of fragile X syndrome.

Impaired thalamic burst firing in fragile X syndrome.

CA2 neurons show abnormal responses to social stimuli in a rat model of Fragile X syndrome.

Morphogen-guided neocortical organoids recapitulate regional areal identity and model neurodevelopmental disorder pathology.

Enhanced accuracy and sensitivity in detecting FMR1 CGG repeats: a multicenter evaluation of a novel PCR-capillary electrophoresis assay.

Autophagy controls the hippocampal postsynaptic organization and affects cognition in a mouse model of Fragile X syndrome.

Scheduled feeding improves behavioral outcomes and reduces inflammation in a mouse model of fragile X syndrome.

FMR1 mutant marmosets show fragile X syndrome phenotypes.

Exaggerated NMDA Receptor-Primed Metaplasticity via SK Channel Dysregulation in Fmr1 Knockout Mice.

Fmr1 knockout disrupts multiple intrinsic properties via reduced HCN channel activity in mediodorsal thalamocortical neurons.

Preliminary perspectives on gene therapy in fragile X syndrome: a caregiver view.

A survey of adult caregivers of people with developmental and epileptic encephalopathies: A long-term care planning needs assessment.

Learning impairments in Fmr1-/- mice on an audio-visual temporal pattern discrimination task.

ROC Analysis of Biomarker Combinations in Fragile X Syndrome-Specific Clinical Trials: Evaluating Treatment Efficacy via Exploratory Biomarkers.

FMR1 Methylation Pattern and Repeat Expansion Screening in a Cohort of Boys with Autism Spectrum Disorders: Correlation of Genetic Findings with Clinical Presentations.

Severe Elimination Disorders and Normal Intelligence in a Case of MAP1B Related Syndrome: A Case Report.

Contrasting Relationships Between Anxiety and Intolerance of Uncertainty in Cornelia de Lange and Fragile X Syndromes.

Reproductive carrier screening for genetic disorders: position statement of the Canadian College of Medical Geneticists.

Prospective study to analyze the yield and clinical impact of trio exome sequencing in 137 Indian children with autism spectrum disorder.

Neurobehavioral profile of individuals with pathogenic variants in CHD3.

Exploring the Relationship Between Fragile X Syndrome and Autism: A Bibliometric Analysis of Global Research Trends.

Interaction between neuromuscular junction metabolic requirements in fragile X syndrome and glycogen storage disease models.

Fragile X and Fatal Rhythms: Electroconvulsive Therapy-Induced Ventricular Tachycardia.

A 30-Year Experience in Fragile X Syndrome Molecular Diagnosis from a Laboratory in Thailand.

High-throughput assessment of FMR1 and SNRPN methylation-based newborn screening using IsoPure and QIAcube HT systems.

Emerging drivers of DNA repeat expansions.

Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review.

Conditional deletion of TRPC1 channel modulates synaptic plasticity, long term depression, and memory extinction in Fragile X syndrome mice.

FMRP-dependent translational control negatively regulates adapter protein complex 2-mediated endocytosis.

Neurosteroids Progesterone and Dehydroepiandrosterone: Molecular Mechanisms of Action in Neuroprotection and Neuroinflammation.

Electroretinographic Findings in Fragile X, Premutation, and Controls: A Study of Biomarker Correlations.

FMRP regulation of STAT3-MYC signaling is critical for adult hippocampal neurogenesis and cognitive flexibility.

Bringing fragile X-associated neuropsychiatric disorders into the phenotypic fold of premutation conditions.

Therapeutic strategies for fragile X syndrome and implications for other gene-silencing disorders.

Gabapentin and Fragile X syndrome: A call to recognize the role of glial cells in neuropsychiatric pharmacology.

Loss of FMRP in microglia promotes degeneration of parvalbumin neurons and audiogenic seizures via progranulin insufficiency.

Late onset of striatal projection neuron hyperexcitability in Fmr1 -/y mice.

Prelinguistic Communication Complexity of Children With Neurogenetic Syndromes.

5-mC DNA methylation in neurodevelopment: from molecular mechanisms to therapeutic implications.

Distinct and shared intrinsic resting-state functional networks in children with idiopathic autism spectrum disorder and fragile X syndrome.

Heart rate defined sustained attention relates to visual attention in autism and fragile X syndrome.

Integration of Ti3C2Tx MXene in the selection of DNA aptamers for FMRP for the diagnosis of fragile X syndrome.

Oxford Nanopore third generation sequencing for analysis of FMR1 5'UTR CGG repeat expansions.

Activity of Human-Specific Interlaminar Astrocytes in a Chimeric Mouse Model of Fragile X Syndrome.

Soy Protein Isolate Affects Blood and Brain Biomarker Expression in a Mouse Model of Fragile X.

FMRP drives mRNP targets into translationally silenced complexes.

Aberrant neural activation during inhibitory control in girls with fragile X syndrome.

Exploring the genetic basis of violence: The impact of Y and X chromosomes.

RNA G-quadruplexes: emerging regulators of gene expression and therapeutic targets.

[Development of Therapeutic Agents Targeting Higher-order Structures of Nucleic Acids in Neurodegenerative Diseases].

Altered auditory feature discrimination in a rat model of Fragile X Syndrome.

FMR1 KH0-KH1 domains coordinate m6A binding and phase separation in Fragile X syndrome.

Computer vision techniques for high-speed atomic force microscopy of DNA molecules.

Couple-Based Carrier Screening: How Gene and Variant Considerations Impact Outcomes.

FMR1: A Neurodevelopmental Factor Regulating Cell Metabolism in the Tumor Microenvironment.

A Transdiagnostic Comparison of Mindfulness and Parenting Stress in Mothers of Children With Autism, Developmental Delay, and Fragile X Syndrome.

Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein.

Quality of life outcomes and predictors for youth with intellectual disability and rare diseases.

Hyper-extralemniscal model of Fragile X syndrome.

Orchestrating Neural Development Through mRNA Translation Regulation.

Interactome of FMRP-N-tat therapeutic unveils key interactions for cellular function in Fragile X neurons.

The influence of parent and couple characteristics on parental responsivity during parent-child interactions in families of children with fragile X syndrome.

Fragile X syndrome: genetic and clinical profile in the Hong Kong Chinese population.

Atypical Retinal Ganglion Cell Function in a Mouse Model of Fragile X Syndrome.

Behavioural difficulties in fragile X syndrome: current pharmacological options and potential future developments.

Longitudinal Analysis of Neuroradiological Biomarkers for Fragile X-Associated Tremor/Ataxia Syndrome and Implications for Clinical Trials.

A Transcriptomic Dataset of Embryonic Murine Telencephalon of Fmr1-Deficient Mice.

Modelling fragile X-associated neuropsychiatric disorders in young inducible 90CGG premutation mice.

A Patient with a Small Deletion Affecting Only Exon 1-Intron 1 of the NXF5 Gene: Potential Evidence Supporting Its Role in Neurodevelopmental Disorders.

The Pharmacokinetics, Dosage, Preparation Forms, and Efficacy of Orally Administered Melatonin for Non-Organic Sleep Disorders in Autism Spectrum Disorder During Childhood and Adolescence: A Systematic Review.

Depression Symptom Trajectories in Mothers With the FMR1 Premutation Vary by CGG Repeat Length: A Longitudinal Study of 73 Women Spanning 20-75 Years of Age.

Better statistical reporting does not lead to statistical rigour: lessons from two decades of pseudoreplication in mouse-model studies of neurological disorders.

Assessing Autism Co-Occurrence in Fragile X Syndrome: Proposing a Preliminary CARS-2 Cut-Off Score.

Cortical layer-specific abnormalities in auditory responses in a mouse model of Fragile X Syndrome.

Frontal cortex hyperactivation and gamma desynchrony in Fragile X syndrome: Correlates of auditory hypersensitivity.

Perineuronal net degradation causes a delayed change in resting and sound evoked responses in the mouse auditory cortex.

Insufficiency of 40S ribosomal proteins, RPS26 and RPS25, negatively affects biosynthesis of polyglycine-containing proteins in fragile-X associated conditions.

Involvement of the Cerebellar Peduncles in FMR1 Premutation Carriers: A Pictorial Review of Their Anatomy, Imaging, and Pathology.

Sex-specific loss of mitochondrial membrane integrity in the auditory brainstem of a mouse model of Fragile X Syndrome.

Awareness and knowledge of pediatricians regarding genetic testing for Fragile X syndrome in Japan: A National Survey of Pediatricians Managing Developmental Delay/Intellectual disability.

Identification of a De Novo Heterozygous Frameshift Variant in FMR1 in a Female With Fragile X Syndrome.